TPST: Tempest Therapeutics, Inc. Stock

by  •  • Comments Off on TPST: Tempest Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.72
Enterprise Value ($M) -0.19
Book Value ($M) 19.13
Book Value / Share 5.47
Price / Book 1.24
NCAV ($M) 9.11
NCAV / Share 2.60
Price / NCAV 2.60

Profitability (mra)
Return on Invested Capital (ROIC) -1.21
Return on Assets (ROA) -0.94
Return on Equity (ROE) -2.03

Liquidity (mrq)
Quick Ratio 2.21
Current Ratio 2.21

Balance Sheet (mrq) ($M)
Current Assets 31.47
Assets 41.49
Liabilities 22.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.03
Net Income -41.84
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.03
Cash from Investing -0.43
Cash from Financing 24.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-11 13D/A Versant Venture Capital VI, L.P. 4.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRA
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-12 4,718 34,123 13.83
2025-05-09 4,210 23,276 18.09
2025-05-08 10,308 48,792 21.13
2025-05-07 8,831 38,126 23.16

(click for more detail)

Similar Companies
TLSA – Tiziana Life Sciences Ltd TNFA – TNF Pharmaceuticals, Inc.
TNXP – Tonix Pharmaceuticals Holding Corp. TRAW – Traws Pharma, Inc.
TSBX – Turnstone Biologics Corp.


Financial data and stock pages provided by
Fintel.io